Dhanvantri Jeevan Rekha Ltd
₹ 19.8
0.00%
25 Nov
11:16 a.m.
About
Incorporated in 1993, Dhanvantri Hospital (a unit of Dhanvantri Jeevan Rekha Limited) is engaged in providing Medical, Diagnostic and Hospital Services.
Key Points
- Market Cap ₹ 8.12 Cr.
- Current Price ₹ 19.8
- High / Low ₹ 27.7 / 11.8
- Stock P/E 13.5
- Book Value ₹ 23.9
- Dividend Yield 0.00 %
- ROCE 2.77 %
- ROE 1.81 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.83 times its book value
- Debtor days have improved from 39.7 to 31.2 days.
Cons
- Promoter holding is low: 19.6%
- Company has a low return on equity of 1.57% over last 3 years.
- Earnings include an other income of Rs.0.34 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.75 | 7.26 | 7.97 | 9.26 | 11.16 | 13.74 | 16.84 | 18.21 | 9.78 | 16.77 | 17.68 | 20.46 | 21.71 | |
| 4.25 | 5.93 | 6.44 | 7.81 | 9.53 | 11.89 | 15.61 | 17.55 | 10.53 | 15.27 | 17.10 | 19.62 | 20.74 | |
| Operating Profit | 1.50 | 1.33 | 1.53 | 1.45 | 1.63 | 1.85 | 1.23 | 0.66 | -0.75 | 1.50 | 0.58 | 0.84 | 0.97 |
| OPM % | 26.09% | 18.32% | 19.20% | 15.66% | 14.61% | 13.46% | 7.30% | 3.62% | -7.67% | 8.94% | 3.28% | 4.11% | 4.47% |
| 0.19 | 0.21 | 0.44 | 0.31 | -0.11 | 0.14 | 0.12 | 0.16 | 0.18 | 0.21 | 0.24 | 0.29 | 0.34 | |
| Interest | 0.03 | 0.01 | 0.08 | 0.08 | 0.18 | 0.22 | 0.11 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.64 | 0.67 | 0.36 | 0.27 | 0.37 | 1.10 | 1.13 | 1.10 | 1.04 | 1.02 | 0.96 | 0.87 | 0.71 |
| Profit before tax | 1.02 | 0.86 | 1.53 | 1.41 | 0.97 | 0.67 | 0.11 | -0.32 | -1.63 | 0.67 | -0.15 | 0.25 | 0.59 |
| Tax % | 16.67% | 39.53% | 29.41% | 32.62% | 43.30% | -7.46% | 63.64% | -15.62% | -12.88% | 28.36% | 46.67% | 36.00% | |
| 0.84 | 0.52 | 1.07 | 0.95 | 0.55 | 0.73 | 0.05 | -0.26 | -1.42 | 0.49 | -0.22 | 0.17 | 0.60 | |
| EPS in Rs | 2.05 | 1.27 | 2.61 | 2.32 | 1.34 | 1.78 | 0.12 | -0.63 | -3.46 | 1.20 | -0.54 | 0.41 | 1.46 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 4% |
| 3 Years: | 28% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | 28% |
| 3 Years: | 28% |
| TTM: | 700% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 16% |
| 3 Years: | 30% |
| 1 Year: | 59% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -3% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 |
| Reserves | 1.98 | 2.50 | 4.29 | 5.25 | 5.79 | 6.52 | 6.57 | 6.30 | 4.88 | 5.37 | 5.15 | 5.32 | 5.65 |
| 0.09 | 0.09 | 0.00 | 0.00 | 1.94 | 1.95 | 0.10 | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.71 | 1.70 | 2.52 | 3.29 | 4.53 | 3.79 | 4.53 | 4.30 | 4.76 | 4.84 | 4.56 | 5.55 | 6.02 | |
| Total Liabilities | 7.93 | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 15.82 |
| 4.95 | 4.57 | 5.05 | 7.80 | 12.07 | 12.28 | 11.44 | 10.68 | 9.72 | 8.85 | 8.54 | 8.14 | 8.11 | |
| CWIP | 0.00 | 0.00 | 1.44 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.98 | 3.87 | 4.47 | 4.89 | 4.34 | 4.13 | 3.79 | 4.17 | 4.14 | 5.51 | 5.32 | 6.88 | 7.71 | |
| Total Assets | 7.93 | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 15.82 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.10 | 1.21 | 0.80 | 1.32 | 3.52 | 0.89 | 1.27 | 1.38 | -0.35 | 1.05 | -0.39 | 2.52 | |
| -0.29 | -1.27 | -1.41 | -1.33 | -4.00 | -0.57 | -0.31 | -0.14 | 0.00 | -0.06 | -0.56 | -0.39 | |
| -0.35 | 0.00 | 0.42 | 0.31 | 0.87 | -0.21 | -1.96 | -0.04 | -0.05 | -0.09 | 0.00 | 0.00 | |
| Net Cash Flow | 0.46 | -0.06 | -0.18 | 0.30 | 0.40 | 0.11 | -1.00 | 1.19 | -0.40 | 0.90 | -0.95 | 2.12 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28.57 | 16.09 | 15.11 | 20.50 | 11.45 | 17.80 | 22.32 | 9.02 | 39.93 | 37.22 | 50.58 | 31.22 |
| Inventory Days | 11.70 | 17.77 | 11.99 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 28.57 | 16.09 | 15.11 | 20.50 | 11.45 | 29.50 | 40.09 | 21.00 | 39.93 | 37.22 | 50.58 | 31.22 |
| Working Capital Days | 25.39 | 72.90 | 66.86 | 56.76 | -35.32 | -26.83 | -17.34 | -32.27 | -53.37 | -25.47 | -3.10 | -32.29 |
| ROCE % | 17.53% | 14.04% | 19.76% | 16.70% | 14.94% | 7.27% | 1.88% | -2.62% | -16.39% | 7.41% | -1.49% | 2.77% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14 Nov - Publication of un-audited financial results for Q2 2024.
- RESULT FOR FINANCIAL RESULT 30.09.2024 14 Nov
-
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
14 Nov - Approved un-audited financial results for Q2 2024.
-
OUTCOME OF THE BOARD MEETING
12 Nov - Approved un-audited financial results for Q2 FY2024.
- RESULT 12 Nov
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Services Offered:[1]
a) Intensive Coronary Care Unit
b) Intensive Care Unit
c) Cardiology
d) Neurology
e) Pulmonology
f) Gastroenterology
g) Gastro Surgery
h) Neuro Surgery
i) Orthopedic Surgery
j) Urology
k) Oral & Maxillofacial Surgery
l) Oncology
m) Otorhinolaryngology
n) Pathology
o) Rehabilitation Program
p) Out Reach Program